Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.262 SEK | -2.60% | +0.77% | -3.32% |
05-24 | Xintela AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-23 | Xintela and EQGen Biomedical to Collaborate to Develop EQSTEM Stem Cell Treatment for Horses | CI |
1st Jan change | Capi. | |
---|---|---|
-3.32% | 14.48M | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- XINT Stock
- News Xintela AB
- Xintela AB Appoints Per Norlén as Chief Medical Officer from 1 July 2021